Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest Expenses (2020 - 2025)

RxSight's Interest Expenses history spans 6 years, with the latest figure at $5000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses changed 0.0% year-over-year to $5000.0; the TTM value through Dec 2025 reached $20000.0, down 9.09%, while the annual FY2025 figure was $19000.0, 9.52% down from the prior year.
  • Interest Expenses reached $5000.0 in Q4 2025 per RXST's latest filing, up from $4000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.6 million in Q2 2023 to a low of $4000.0 in Q4 2023.
  • Average Interest Expenses over 5 years is $598950.0, with a median of $464000.0 recorded in 2021.
  • Peak YoY movement for Interest Expenses: soared 35866.67% in 2021, then tumbled 99.72% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $1.1 million in 2021, then surged by 34.48% to $1.5 million in 2022, then tumbled by 99.72% to $4000.0 in 2023, then increased by 25.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Interest Expenses are $5000.0 (Q4 2025), $4000.0 (Q3 2025), and $5000.0 (Q2 2025).